최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기The egyptian heart journal : (Ehj) : official bulletin of the egyptian society of cardiology, v.68 no.4, 2016년, pp.253 - 259
Khamis, H. , Sanad, O. , Elrabbat, K. , Attia, A. , Adel, M. , Alkady, H. , Masoud, A.
Background: The newer generation of Bioresorbable Vascular Scaffold ABSORB (BVS 1.1) showed better outcome in regard to scaffold area reduction as a result of improved scaffold design and enhanced polymer processing. Objective: To assess the safety and efficacy of treating significant native coronar...
Circulation Mintz 94 35 1996 10.1161/01.CIR.94.1.35 Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study
Catheter Cardiovasc Interv Zartner 66 590 2005 10.1002/ccd.20520 First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby
Circulation Kimura 105 2986 2002 10.1161/01.CIR.0000019743.11941.3B Long-term clinical and angiographic follow up after coronary stent placement in native coronary arteries
Lancet Stettler 370 937 2007 10.1016/S0140-6736(07)61444-5 Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
JACC Cardiovasc Interv Kandzari 6 504 2013 10.1016/j.jcin.2012.12.125 Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with 9 first-generation drug-eluting and bare-metal stents
Postepy Kardiol Interwencyjnej Rzeszutko 9 22 2013 Biodegradable vascular scaffold ABSORB BVS - scientific evidence and methods of implantation
Hellenic J Cardiol Gogas 53 301 2012 The ABSORB Bioresorbable Vascular Scaffold: an evolution or revolution in interventional cardiology?
Lancet Serruys 373 897 2009 10.1016/S0140-6736(09)60325-1 A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
The Egypt Heart J Khamis 66 227 2014 10.1016/j.ehj.2013.09.005 Bioresorbable Vascular Scaffold (ABSORB BVS); first report in Egyptian patients with 6 month angiographic/IVUS follow up
Circ Cardiovasc Interv Otsuka 7 330 2014 10.1161/CIRCINTERVENTIONS.113.000990 Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model
Circulation Thygesen 126 2020 2012 10.1161/CIR.0b013e31826e1058 Third universal definition of myocardial infarction
J Interv Cardiol Garrone 22 527 2009 10.1111/j.1540-8183.2009.00491.x Quantitative coronary angiography in the current era: principles and applications
Brink 1 2010 Essentials of statistics
ABSORB Jpn Eur Heart J Kimura 2015 10.1093/eurheartj/ehv435 A randomized trial evaluating everolimus eluting Absorb bioresorbable scaffolds vs everolimus eluting metallic stents in patients with coronary artery disease
Eur Heart J Kristensen 2015 10.1093/eurheartj/ehv459 Deliver the drug and be resorbed: Evidence from ABSORB Japan
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.